òòò½Íø

Biography

Dr Bernett Lee graduated from the National University of òòò½Íøwith a Bachelor of Science in Biology and went on to do a Doctor of Philosophy in Bioinformatics focusing on the analysis of alternative splicing using computational methods. After graduation, he worked for The Blueprint Initiative as the manager of High Throughput Biology aiding the creation of BIND (Biomolecular Interaction Network Database), a database of protein to protein interactions. He then moved to the Bioinformatics Institute where he supported collaborative research activities in the area of neurobiology, biomarker selection and intermediate filaments. When Thomson Reuters acquired the intellectual property of BIND, he joined them to further develop the database as part of Thomson Reuters life science portfolio. When Eli Lilly opened the Lilly SIngapore Centre For Drug Discovery, he joined the Integrative Computational Science (ICS) group to work on drug target identification and PK/PD (pharmacokinetics and pharmacodynamics). The solution that was developed at Eli Lilly for PK/PD was a success earning it a mention in the article "20 Great Ideas To Steal" in InformationWeek 500. Following the closure of the centre, he moved to SIgN as part of the Bioinformatics core supporting the institute in all manner of data analysis. Dr Lee led the Computational Immunology group at SIgN, which collaborated with both internal research groups and other groups in the local landscape. He currently supports LKCMedicine as their Director for Centre for Biomedical Informatics.

RESEARCH FOCUS

• Bioinformatics
• Multimodal data integration and analysis

PUBLICATIONS